1. Aspiration pneumonia induces muscle atrophy in the respiratory, skeletal, and swallowing systems. Issue 4 (22nd May 2018) Authors: Komatsu, Riyo; Okazaki, Tatsuma; Ebihara, Satoru; Kobayashi, Makoto; Tsukita, Yoko; Nihei, Mayumi; Sugiura, Hisatoshi; Niu, Kaijun; Ebihara, Takae; Ichinose, Masakazu Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 9:Issue 4(2018) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Beneficial effects of sunitinib on tumor microenvironment and immunotherapy targeting death receptor5. (1st February 2019) Authors: Tsukita, Yoko; Okazaki, Tatsuma; Ebihara, Satoru; Komatsu, Riyo; Nihei, Mayumi; Kobayashi, Makoto; Hirano, Taizou; Sugiura, Hisatoshi; Tamada, Tsutomu; Tanaka, Nobuyuki; Sato, Yasufumi; Yagita, Hideo; Ichinose, Masakazu Journal: Oncoimmunology Issue: Volume 8:Number 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical features of COVID-19 patients with rebound phenomenon after corticosteroid therapy. Issue 1 (5th September 2022) Authors: Murakami, Koji; Sano, Hirohito; Tode, Naoki; Tsukita, Yoko; Sato, Kei; Narita, Daisuke; Kimura, Nozomu; Matsumoto, Shuichiro; Ono, Yoshinao; Iwasaki, Chikashi; Sugiyama, Hatsumi; Suzuki, Manami; Kakuto, Sho; Konno, Shuichi; Kanamori, Hajime; Baba, Hiroaki; Oshima, Kengo; Takei, Kentarou; Tokuda, ... Journal: BMJ open respiratory research Issue: Volume 9:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study. (26th November 2019) Authors: Tateishi, Kazunari; Ko, Ryo; Shukuya, Takehito; Okuma, Yusuke; Watanabe, Satoshi; Kuyama, Shoichi; Murase, Kyoko; Tsukita, Yoko; Ashinuma, Hironori; Nakagawa, Taku; Uematsu, Kazutsugu; Nakao, Mika; Mori, Yoshiaki; Kaira, Kyoichi; Mouri, Atsuto; Miyabayashi, Takao; Sakashita, Hiroyuki; Matsumoto, ... Journal: Oncologist Issue: Volume 25:Number 4(2020) Page Start: e668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EGFR Mutation Analysis of Circulating Tumor DNA Using an Improved PNA-LNA PCR Clamp Method. (13th July 2016) Authors: Watanabe, Kana; Fukuhara, Tatsuro; Tsukita, Yoko; Morita, Mami; Suzuki, Aya; Tanaka, Nobuyuki; Terasaki, Hiroshi; Nukiwa, Toshihiro; Maemondo, Makoto Other Names: Giovannetti Elisa Academic Editor. Journal: Canadian respiratory journal Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First-line therapy in non-small cell lung cancer patients with EGFR activating mutations: a consideration of the clinical position of osimertinib based on the subset of Japanese patients in the FLAURA study. (22nd April 2022) Authors: Tsukita, Yoko; Inoue, Akira Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 5(2022) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunotherapy-related hepatitis and thrombocytopaenia induced by the very low dose of only 90 mg of atezolizumab. (July 2020) Authors: Tsukita, Yoko; Miyauchi, Eisaku; Fukudo, Masahide; Sasaki, Takaaki; Ichinose, Masakazu Journal: European journal of cancer Issue: Volume 133(2020) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study. (July 2021) Authors: Tsukita, Yoko; Yamamoto, Takaya; Mayahara, Hiroshi; Hata, Akito; Takeda, Yuichiro; Nakayama, Hidetsugu; Tanaka, Satoshi; Uchida, Junji; Usui, Kazuhiro; Toyoda, Tatsuya; Tamiya, Motohiro; Morimoto, Masahiro; Oya, Yuko; Kodaira, Takeshi; Miyauchi, Eisaku; Jingu, Keiichi; Sugiura, Hisatoshi Journal: Radiotherapy and oncology Issue: Volume 160(2021) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT). (December 2021) Authors: Sakata, Yoshihiko; Sakata, Shinya; Oya, Yuko; Tamiya, Motohiro; Suzuki, Hidekazu; Shibaki, Ryota; Okada, Asuka; Kobe, Hiroshi; Matsumoto, Hirotaka; Yokoi, Takashi; Sato, Yuki; Uenami, Takeshi; Saito, Go; Tsukita, Yoko; Inaba, Megumi; Ikeda, Hideki; Arai, Daisuke; Maruyama, Hirotaka; Hara, Satoshi... Journal: European journal of cancer Issue: Volume 159(2021) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203. (January 2020) Authors: Tsukita, Yoko; Inoue, Akira; Sugawara, Shunichi; Kuyama, Shoichi; Nakagawa, Taku; Harada, Daijiro; Tanaka, Hisashi; Watanabe, Kana; Mori, Yoshiaki; Harada, Toshiyuki; Hino, Toshihiko; Fujii, Masanori; Ichinose, Masakazu Journal: Lung cancer Issue: Volume 139(2020) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗